HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea · Delayed Price · Currency is KRW 2,400.00
+45.00 (1.91%)
Aug 12, 2026, 3:30 PM KST
HLB Therapeutics Market Cap
HLB Therapeutics has a market cap or net worth of 218 billion as of August 11, 2026. Its market cap has decreased by -25.83% in one year.
Market Cap
218.00B
Enterprise Value
263.76B
Revenue
67.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,400.00
ChartMarket Cap Chart
Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 218.00B, an increase of 106.04%. That is a compound annual growth rate of 4.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 218.00B | -13.45% |
| Dec 30, 2025 | 251.87B | -73.05% |
| Dec 30, 2024 | 934.49B | 182.02% |
| Dec 28, 2023 | 331.36B | -9.25% |
| Dec 29, 2022 | 365.14B | -3.64% |
| Dec 30, 2021 | 378.91B | -51.22% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteina | 285.81B |
| BINEX | 221.02B |
| GC Cell | 219.85B |
| EASY BIO,Inc. | 208.42B |
| Bioneer | 178.35B |
| Anterogen.Co.,Ltd. | 169.40B |
| JETEMA, | 162.20B |
| Helixmith | 156.56B |